Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 7;24(24):17224.
doi: 10.3390/ijms242417224.

Hepatitis B Virus and microRNAs: A Bioinformatics Approach

Affiliations
Review

Hepatitis B Virus and microRNAs: A Bioinformatics Approach

Verdiana Zulian et al. Int J Mol Sci. .

Abstract

In recent decades, microRNAs (miRNAs) have emerged as key regulators of gene expression, and the identification of viral miRNAs (v-miRNAs) within some viruses, including hepatitis B virus (HBV), has attracted significant attention. HBV infections often progress to chronic states (CHB) and may induce fibrosis/cirrhosis and hepatocellular carcinoma (HCC). The presence of HBV can dysregulate host miRNA expression, influencing several biological pathways, such as apoptosis, innate and immune response, viral replication, and pathogenesis. Consequently, miRNAs are considered a promising biomarker for diagnostic, prognostic, and treatment response. The dynamics of miRNAs during HBV infection are multifaceted, influenced by host variability and miRNA interactions. Given the ability of miRNAs to target multiple messenger RNA (mRNA), understanding the viral-host (human) interplay is complex but essential to develop novel clinical applications. Therefore, bioinformatics can help to analyze, identify, and interpret a vast amount of miRNA data. This review explores the bioinformatics tools available for viral and host miRNA research. Moreover, we introduce a brief overview focusing on the role of miRNAs during HBV infection. In this way, this review aims to help the selection of the most appropriate bioinformatics tools based on requirements and research goals.

Keywords: antiviral treatment; bioinformatics tools; biomarkers; chronic infection; hepatitis B virus; infectious diseases; microRNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The interplays between viral and host (human) miRNAs during viral infection.

References

    1. Tong S., Revill P. Overview of Hepatitis B Viral Replication and Genetic Variability. J. Hepatol. 2016;64:S4–S16. doi: 10.1016/j.jhep.2016.01.027. - DOI - PMC - PubMed
    1. Jeng W.-J., Papatheodoridis G.V., Lok A.S.F. Hepatitis B. Lancet. 2023;401:1039–1052. doi: 10.1016/S0140-6736(22)01468-4. - DOI - PubMed
    1. Wei L., Ploss A. Core Components of DNA Lagging Strand Synthesis Machinery Are Essential for Hepatitis B Virus cccDNA Formation. Nat. Microbiol. 2020;5:715–726. doi: 10.1038/s41564-020-0678-0. - DOI - PMC - PubMed
    1. Königer C., Wingert I., Marsmann M., Rösler C., Beck J., Nassal M. Involvement of the Host DNA-Repair Enzyme TDP2 in Formation of the Covalently Closed Circular DNA Persistence Reservoir of Hepatitis B Viruses. Proc. Natl. Acad. Sci. USA. 2014;111:E4244–E4253. doi: 10.1073/pnas.1409986111. - DOI - PMC - PubMed
    1. Karayiannis P. Hepatitis B Virus: Virology, Molecular Biology, Life Cycle and Intrahepatic Spread. Hepatol. Int. 2017;11:500–508. doi: 10.1007/s12072-017-9829-7. - DOI - PubMed